The disparity between supply and demand of organs for transplantation continues to grow, and the organ shortage has made it necessary to liberalize acceptance criteria to include donors beyond traditional criteria. These donors collectively are known as extended criteria donors…
Portal hypertension is most commonly a manifestation of underlying liver parenchymal disease and worsens with increasing severity of cirrhosis. It is responsible for complications, such as the development of varices and variceal hemorrhage, among chronic liver disease patients and often…
Biliary atresia (BA) is the result of an idiopathic, progressive, fibroinflammatory process that affects intra hepatic and extrahepatic bile ducts. It typically presents in the first few weeks of life and without early recognition and surgical treatment progresses rapidly to…
Background Cholangiocarcinoma (CCA), first described by Durand-Fardel in 1840, is a malignant neoplasm arising from epithelial cells of the extrahepatic and intrahepatic bile ducts, excluding the papilla of Vater and the gallbladder. CCA is the second most common primary hepatobiliary…
Liver transplantation is the gold standard treatment for patients with end-stage liver disease. The great success of liver transplantation has produced a ripple effect on many other medical and scientific disciplines and, in particular, on general and hepatobiliary surgery. The…